Epirubicin: an anthracycline of minor cardiotoxicity
Rivero, O.; Mordeglia, F.
Medicina 47(3): 320-321
1987
ISSN/ISBN: 0025-7680 PMID: 3481643 Document Number: 291594
Document emailed within 1 workday
Related Documents
Wojtukiewicz, M.Z.; Omyła, J.; Kozłowski, L.; Szynaka, B. 2000: Cardiotoxicity of anthracycline Postepy Higieny i Medycyny Doswiadczalnej 54(4): 467-485Lechner, W.; Zechmann, W.; Mayr, P.; Reider, W.; Marth, C. 1988: On the problem of the cardiotoxicity of epirubicin-cisplatin Zentralblatt für Gynakologie 110(7): 429-432
Lipshultz, S.E.; Sanders, S.P.; Goorin, A.M.; Krischer, J.P.; Sallan, S.E.; Colan, S.D. 1994: Monitoring for anthracycline cardiotoxicity Pediatrics 93(3): 433-437
McGuire, W.P. 1978: Prospective monitoring for anthracycline cardiotoxicity: an introduction Cancer Treatment Reports 62(6): 855
2008: Dexrazoxane: a second look. Prevention of anthracycline cardiotoxicity: useful for some patients Prescrire international 17(97): 195
Orditura, M.; De Vita, F.; Ciaramella, F.; Catalano, G. 1994: Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 9(4): 243-248
Ferrans, V.J. 1978: Overview of cardiac pathology in relation to anthracycline cardiotoxicity Cancer Treatment Reports 62(6): 955-961
De Leonardis, V.; De Scalzi, M.; Neri, B.; Bartalucci, S.; Cinelli, P. 1987: Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens International Journal of Clinical Pharmacology Research 7(4): 307-311
Okada, Y.; Horikawa, K.; Sano, M. 1997: Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(5): 585-589
McGovren, J.P.; Neil, G.L.; Denlinger, R.H.; Hall, T.L.; Crampton, S.L.; Swenberg, J.A. 1979: Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent Cancer Research 39(12): 4849-4855
Ali, A.A.S.; Al-Mudhafar, A.M.J. 2011: Prediction of anthracycline induced cardiotoxicity: study of thirty-one Iraqi adult patients Gulf Journal of Oncology 10: 33-39
Lemez, P.; Maresová, J. 1996: Protective effects of cardioxane against anthracycline-induced cardiotoxicity in relapsed acute myeloid leukemias Neoplasma 43(6): 417-419
Liu, L.; Liu, Z-zhe.; Liu, Y-ye.; Zheng, Z-dong.; Liang, X-feng.; Han, Y-ling.; Xie, X-dong. 2013: Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 35(12): 936-940
Patel, C.D.; Balakrishnan, V.B.; Kumar, L.; Naswa, N.; Malhotra, A. 2010: Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity? Hellenic Journal of Nuclear Medicine 13(3): 233-237
Beaulieu, A.J. 1993: The IR-4 Project. A national program for the approval of new animal drugs for minor species and minor uses. Accomplishments and goal for minor ruminants Veterinary and Human Toxicology 35 Suppl. 2: 10-11
Papadopoulos, O. 2004: Minor species/minor indications: legal provisions, definition criteria and policies to be considered Developments in Biologicals 117: 131-135
Vannier, P. 2004: Vaccines for minor use and minor species: technical difficulties to solve and consequences in legal definitions Developments in Biologicals 117: 137-140
Jones, P.G.H. 2004: Consideration of alternative licensing procedures for vaccines for minor species, minor indications and autogenous/autologous products Developments in Biologicals 117: 153-158
Nolen, R.S. 2000: Lawmakers mull over minor use/minor species bill Journal of the American Veterinary Medical Association 217(4): 460-461
Megale, P.; Angulo, J.J.; Pederneiras, C.A. 1979: Variola minor in Bragança Paulista county, 1956. Observations on the clinical course of variola minor and on pregnancy in women with the disease Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 72(1): 11-20